Radar › Screener › JAGX

JAGX

Jaguar Health, Inc.
JAGX stock: dilution, reverse split — what the SEC filings say, updated every weekday morning.
Nasdaq · Pharmaceutical Preparations · EDGAR filings (CIK 1585608) · 13 signals · 0 setups · updated Sep 22, 2026

What the filings say Pressure ▼

The company can sell stock into the market any day at prevailing prices — steady supply.

Radar 67 (elevated attention) · dilution pressure high · listing risk high · governance risk elevated · runway 3.7 mo · strongest signal: Offering (424B) (Sep 3, 2026)

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

Get tomorrow's read on JAGX — free
One email every weekday morning: what changed across JAGX and ~1,400 other microcaps, every claim linked to the filing.
67Radar · attention score (0–100)
82Dilution pressure · financing + balance sheet
76Listing risk · exchange standards
40Governance risk · reporting, auditor, going concern

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on JAGX
Alerts
One email the morning JAGX files anything that matches your rules (types, minimum score, setups).
12-month history
Every signal and setup for JAGX back a year, not just 30 days — see how the current setup built.
Full analyst notes
What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV
All 892 flagged companies, same-day, sortable and exportable.
Get Pro · $18.85/mo founding rate   See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$7.3Mcash + short-term investments as of Mar 31, 2026
3.7 moestimated runway (latest fiscal-year operating cash flow (quarter too short to annualize) [companyfacts])
n/astockholders' equity
$3.8Mpublic float (10-K cover)
n/ashares outstanding

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 175 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

DateSignalEvidenceScore
Sep 21, 2026▼ Reverse split “reverse split” language in 8-K (8-K) filed 2026-09-21 filing 40
Sep 21, 2026▼ Holder rights modified 8-K Item 3.03 filed 2026-09-21 (accepted 16:47 ET) filing 24
Sep 18, 2026▼ Reverse split “reverse split” language in PRE 14A (PRE 14A) filed 2026-09-18 filing 30
Sep 15, 2026▼ Reverse split “reverse split” language in 8-K (8-K) filed 2026-09-15 filing 40
Sep 15, 2026▼ PIPE “pipe” language in 8-K (EX-10.5) filed 2026-09-15 filing 38
Sep 15, 2026▼ Reverse split “reverse split” language in 8-K (EX-4.1) filed 2026-09-15 filing 35
Sep 15, 2026▼ Unregistered sale 8-K Item 3.02 filed 2026-09-15 (accepted 13:44 ET) filing 32
Sep 15, 2026▼ Holder rights modified 8-K Item 3.03 filed 2026-09-15 (accepted 09:10 ET) filing 26
Sep 3, 2026▼ Offering (424B) 424B5 prospectus supplement 2026-09-03; 4 prior 424B filings in 12m filing 49
Sep 3, 2026▼ ATM program “atm” language in 424B5 (424B5) filed 2026-09-03 filing 40
Mar 31, 2026▼ Runway < 6 months ~3.7 months runway: liquidity $7,278,000 as of 2026-03-31, burn $23,686,000/yr (latest fiscal-year operating cash flow (quarter too short to annualize) [companyfacts]) filing 32
Mar 31, 2026▼ Near $5M MVLS floor Public float $3,800,000 (as of 2025-06-30) vs $5M Nasdaq MVLS floor; needs price x shares confirmation filing 28
Mar 31, 2026▼ Cash < current liabilities Liquidity $7,278,000 vs current liabilities $40,686,000 filing 22
Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans